How the Novavax coronavirus vaccine uses moth cells

Videos

Novavax, a biotech company in Gaithersburg, Md., uses recombinant protein technology to create their coronavirus vaccine. It has been highly anticipated by many experts, because it would add a more traditional technology to the portfolio of coronavirus vaccines in the United States. Other vaccines work by instructing the body’s cells to build the spiky proteins…